首页> 外文OA文献 >Unexpected intrauterine death following resolution of hydrops fetalis after betamethasone treatment in a fetus with a large cystic adenomatoid malformation of the lung
【2h】

Unexpected intrauterine death following resolution of hydrops fetalis after betamethasone treatment in a fetus with a large cystic adenomatoid malformation of the lung

机译:在患有大量囊性腺瘤样肺部畸形的胎儿中进行倍他米松治疗后胎儿水肿消失后出现意外的宫内死亡

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Without intervention, the development of hydrops fetalis secondary to cystic adenomatoid malformation of the lung (CAML) implies a 100% mortality rate. Conversely, four CAML cases with in-utero resolution of hydrops fetalis after prenatal betamethasone therapy with good clinical outcome have been reported in the literature. The mechanism is speculated to be the effect of corticosteroid in improving lung maturation. Here we present another CAML case with resolution of hydrops fetalis after prenatal betamethasone therapy but which was followed by later intrauterine death. We speculate that the resolution of the CAML lesion itself may be more important in determining the clinical outcome than the resolution of hydrops. The association between prenatal betamethasone therapy and resolution of hydrops may be related to a different mechanism other than improvement of lung maturation. Copyright © 2005 ISUOG. Published by John Wiley & Sons, Ltd.
机译:在没有干预的情况下,继发于肺囊性腺瘤样畸形(CAML)的胎儿积水的发展意味着死亡率为100%。相反,文献报道了4例产前倍他米松治疗后胎儿宫内积水的CAML病例,临床效果良好。推测该机制是皮质类固醇改善肺成熟的作用。在这里,我们介绍了另一例产前倍他米松治疗后胎儿水肿消失的CAML病例,但随后子宫内死亡。我们推测,在确定临床结果方面,CAML病变本身的解决可能比积液的解决更为重要。产前倍他米松治疗与水肿消退之间的关联可能与改善肺成熟程度不同的机制有关。版权所有©2005 ISUOG。由John Wiley&Sons,Ltd.出版

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号